<h4>Background</h4>Abnormal orexin-A levels in cerebrospinal fluid (CSF) have been identified in Alzheimer's disease (AD) and other neurodegenerative diseases. Here, HCRT is linked to early-onset autosomal dominant Alzheimer disease.